COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry

By Mark Hilton, Marc Martens, Sally Shorthose

04-2020

COVID-19 presents an unprecedented challenge to the global life sciences industry. Members of our International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships with regulatory bodies, have worked together to provide an update in the form of a Q&A for each of the countries we are located. This update aims to provide guidance on the responses of EU and Asia-Pac regulators in the areas of clinical trials, medical devices, market access, public procurement and compulsory licensing.

COVID-19: Legislation Tracker for Medical Devices, read here

COVID-19: Legislation Tracker for Clinical Trials, read here

COVID-19: Legislation Tracker for Public Procurement, read here
 
COVID-19: Legislation Tracker for State Use/Compulsory Licensing, read here

COVID-19: Legislation Tracker for Market Access
, read here